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INTRODUCTION
Sickle cell anaemia is characterized by hemolytic anemia
and vaso-occlusion leading to acute and chronic tissue
ischemia, infarction, chronic organ damage and organ
dysfunction. One of the earliest organs to be affected
by recurrent infarction and progressive damage is the
spleen1. The spleen serves both haematological and
immunological functions. Variability of  haemoglobin
level with splenomegaly has been documented in both
peadiatric and adult sickle cell anaemia patients 2,3 with
few documentations on autosplenectomy.
Haematological functions of the spleen includes:
erythropoiesis, maturation of the reticulocyte,
lymphopoiesis, reservoir of  blood cells, pitting and
culling function and destruction of old red cells 4. The
spleen presents a hypoxic, acidic and hypoglycemic
environment for the erythrocytes resulting in sickled
red cells due to the limited oxygen and glucose. The
sickling leads to repeated infarctions of the spleen and
subsequent reduction of both morphological size and
function of the spleen. The splenic sizes in patients
with sickle cell anaemia vary with the degree of insult
it has received, thereby giving rise to a spectrum of
sizes, from repeated infarction. One extreme is
splenomegaly observed during infancy and early
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Background:  The spleen serves critical haematological and immunological
functions in the body. However it is also the first organ to be affected by the effects
of sickling in sickle cell anaemia. While the splenic size has been evaluated in
sickle cell anaemia, the spleen sizes of these patients has not been associated with
any specific haematological pattern.
Objectives:  To determine the haematological parameters of  patients with sickle
cell anaemia (SCA) in relation to spleen size.
Methods: The full blood count (FBC), the irreversibly sickled cells and blood
transfusion use  amongst SCA patients in steady state was evaluated. Abdominal
ultrasound was also performed for all patients and HbAA control for splenic size
categorization.
Results:  Forty patients with SCA and 22 controls with HbAA were studied with
mean age of  29.28 ± 8.10 years 28.23 ± 8.14 years respectively. The mean splenic
longitudinal lengths in patients and controls were 6.3 ± 4.3cm and 8.9 ± 1.5 cm
respectively (p-value < .05).
The mean haematocrit and haemoglobin value were significantly lower in SCA
cases than in controls (p < 0.001). Though the red cell indices were similar but the
white blood cell and platelet count were significantly higher in patients than in
controls.
Among SCA cases, the spleen size showed significant positive correlation with
haematocrit (r = 0.371, p = 0.019) and the age at 1st transfusion (r = 0.447, p = 0.013)
but significant negative correlation with MCV, MCH, MCHC and platelet count.
Above 80% of patients with severe, moderate and mild autosplenectomy had been
transfused compared to 25% of  patients with splenomegaly.
Conclusions: Similarities in red cell indices between patients and controls suggests
an identical factor influencing the red cell indices which could be genetic such as
thalassemia or environmental such as iron deficiency. The negative correlation of
the spleen size with red cell indices, white cell count and platelet count and positive
correlation with haematocrit suggest that spleen size can be used to determine
clinical course of the disease.  Earlier age at first transfusion, significantly higher
frequency of blood transfusion and MCHC in patients with severe autosplenectomy
suggest a more severe clinical course when compared with patients with
splenomegaly, normal spleen, mild and moderate autosplenomegaly.
Keywords: Sickle cell anaemia, Splenic size, Autosplenectomy, Haematological parameters
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childhood, consequent to splenic sequestration or
during adulthood due to increased demand on the
spleen to perform its functions2,3. The other extreme
is autosplenectomy which appears as a small wrinkled
firm, nodular remnant following progressive atrophy
due to repeated episodes of vaso-occlusion and
infarction5.
The clinical and laboratory profile of patients with
sickle cell anaemia are continuously being studied to
understand the biology of  the disease 6,7. The
haematological parameters are the most commonly
requested investigation to determine the line of
management, adjust therapy and predict outcome. The
various types of SCD manifest considerable
differences in haematological parameters8. These
differences are further complicated by both
physiological factors and acute or chronic complications.
A change in the size of the spleen is a chronic
complication which is postulated to affect
haematological parameters and could also be associated
with a unique clinical course. Paediatric patients with
splenomegaly have lower mean haematocrit;
retrospective analysis of their case files showed that
these  patients had predominantly anaemic crises while
those without splenomegaly had had predominantly
vaso-occlusive crises9,10. An enlarged spleen is rare in
adults with sickle cell anaemia.11 Functional changes
of the spleen is related to anatomic regression of the
spleen11. The slower progression to atrophy is the result
of a reduced tendency to sickling in vivo therefore
adult sickle cell patients who retain their spleen are
judged to have less severe clinical disease. However an
inverse relationship between severity and
autosplectomy has been reported when blood
transfusion was used to determine clinical severity 12.
A study by Awotua-Efebo et al showed that
splenomegaly is associated with poorer haematological
indices whilst autosplenectomy is associated with better
indices.10 The transitory anatomic size of  spleen
between normal and autosplenectomy are not well
recognized and studied. The patients with SCA require
regular monitoring and evaluation for various reasons,
therefore the knowledge of changes in haematological
indices of patients induced by variation in splenic size
may be useful in the management of patient. Most of
the local literatures relating the spleen size to the
haematological parameters have been in paediatric
sickle cell anaemia patients and were not related to
blood transfusion requirements13,14. The spleen in sickle
patients in sub Saharan Africa is believed to be different
from that of sickle cell patients outside sub Saharan
Africa15. Therefore there is a need to generate local
data to better understand the pathogeneses of the
disease in our environment. This study aims to identify
the link between haematological parameters, blood
transfusion history and variations in spleen size of
patients with sickle cell anaemia.
METHODS
This was a cross sectional study conducted amongst
Sickle cell anaemia patients in steady state attending
Haematology Clinic of  the University College Hospital
Ibadan, Nigeria. The diagnoses of patients and controls
were confirmed using haemoglobin electrophoresis
at alkaline pH. The controls were haemoglobin AA
apparently healthy age and sex matched individuals.
Ethical approval was obtained from the joint UI/UCH
Ethics committee. Written and verbal consents were
obtained from each participant. Consecutive patients
with SCA who were in steady state were recruited
into the study. The exclusion criteria were; history of
blood transfusion in the last 3 months, other sickle
haemoglobin phenotypes, patients on hydroxyurea and
previous history of  surgery. Interviewer administered
questionnaire was used to collect the following
information from all participant: demographic
characteristics, past medical history, drugs and blood
transfusion history. The medical history included clinical
problem of first presentation and age at diagnosis,
numbers of painful crises and hospital admissions in
the last one year, number of units of blood transfused
in the patient’s lifetime. None of  the patients was on
hydroxyurea.
Three milliliters of blood was collected from both
patients and controls into ethylenediamine- tetraacetic
acid (EDTA) bottle for full blood count (FBC). The
sample for full blood count was analyzed immediately
using sysmex autoanalyzer Kobe, Japan. The following
parameters were determined; haemoglobin
concentration (Hb), haematocrit (Hct), red blood cell
count (RCC), mean corpuscular haemoglobin (MCH),
mean cell volume (MCV), mean corpuscular
haemoglobin concentration (MCHC), white cell count
(WCC) and differentials,  and platelet count (plt ct).
The irreversibly sickled cells (ISC) were manually
estimated as percentages of the total red cells
enumerated from blood films made with the
Leishman stain and examined under high power
microscope (X100) field as described by Dacie and
Lewis16. Patients were sent for abdominal ultrasound
immediately samples for FBC were collected.
Ultrasonographic evaluation
All SCA cases and controls were scanned using an
Ultrasonix SP ultrasound machine with a 3 – 5 MHz
curvilinear transducer. In the posterior axillary line in
the area of the 10th rib was located and scanned
through the intercostal space to have the entire the
longitudinal view of  the spleen with the hilus. In this
position, maximum length were measured between
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the most superomedial and the most inferolateral points
of the spleen.
Splenic sizes were determined by ultrasonographically
measured craniocaudal lengths of the spleen in our
subjects. In this study, we categorized splenic sizes into
three groups; Splenomegaly, normal size and
autosplenectomy. A splenic length of  7cm – 13 cm
was regarded as normal in this study, according to the
generally accepted values 17, 18.  Autosplenectomy were
splenic lengths < 6cm according to the report of Ojo
et al.15 Autopslenectomy was further categorized in this
study as; severe-absence of a spleen or splenic tissue
less than 1cm in the absence of any history of
splenectomy 5, 13.  Moderate form was defined as the
long axis of the spleen measured < 1cm but less than
5.0cm (regarded as shrunken by some researchers)
while Splenomegaly was defined when the long axis
of  the organ longer than 13.0cm 17,18. Furthermore,
we classified splenic lengths >5.0cm but < 6.9cm as
mild splenectomy.
Statistical analysis
Data were analyzed using SPSS version 23 (Statistical
Package for Social Sciences, Inc., Chicago, Ill). The
descriptive data were given as means ± standard
deviation (SD) for continuous variable and frequency
and percentages for categorical data. ANOVA was
used to determine the significance of  differences in
more than 2 variables. Spearman correlation was used
to determine the relationship between the splenic sizes
and haematological parameters. Chi square was used
to determine significance among proportional
variables. Logistic regression was used to determine
the degree of association. The differences were
considered to be statistically significant when the p value
obtained was < 0.05.
RESULTS
Demographic and clinical characteristic of
patients
A total of 40 patients with SCA and 22 apparently
healthy HbA controls were recruited. The mean age
of patients was 29.3 ± 8.1 years while the mean age
of  the controls was 28.2 ± 8.1 years. The male: female
ratio for patients and controls were 1: 1.3 and 1.1:1
respectively.
Sickle cell anaemia was diagnosed in most of the cases
(52.5%) at childhood, while only one case (2.5%) was
diagnosed at adulthood in the study population. The
commonest first clinical presentation was dactylitis in
62.5% of the patients while splenomegaly was the least
first clinical presentation in 5% of  cases. In the
preceding one year of  study, 90% of  the patients
presented at the hospital with vaso-occlusive crises.
Aplastic crises were the least documented presentation
in only 2.5%. Ninety percent of the patients have been
admitted for hospital management while 77.5% had
received blood transfusion.
Splenic size evaluation on Ultrasonography and
haematological profile of patients and controls
The spleen size was smaller than normal in most
patients with SCA (70%) while about 20% and 10%
had severe autosplenectomy and splenomegaly
respectively (Figure 1). Among the controls (90.9%)
had normal splenic size and 9.1% had mild reduction
in size. None of the controls had splenic size that was
classified as splenomegaly, moderate or severe
autosplenectomy.
There was statistically significant difference between
the mean spleen length of cases (6.3 ± 4.3cm) and
controls (8.9 ± 1.5cm) (p = 0.001). The mean Hct and
Hb value for patients were significantly lower than the
value for controls (p < 0.001) while the WCC and
platelet count were significantly higher in cases than in
controls (Table 1). There was no difference in the red
cell indices between the 2 groups.
Haematological parameters of patients with
spleen size
There was a significant difference in the Hct, Hb, MCV
and MCH values among SCA cases with different
splenic sizes [p =0.006, 0.013, 0.038 and 0.008
respectively]. Post-hoc test (Tukey’s HSD; Honest
Significance difference test) showed that MCV and
Variables SCA Cases HbAA Controls P-value± ±
Age(years) 29.3 ± 8.1 28.2 ± 8.1 0.628
Splenic Size(cm) 6.3 ± 4.3 8.9 ± 1.5 0.001
Haematocrit (%) 25.5 ± 5.3 40.0 ± 4.5 <0.001
Haemoglobin (g/l) 76.6 ± 15.9 119.2 ± 13.6 <0.001
MCV (fl) 89.2 ± 9.5 87.1 ± 5.8 0.353
MCH(pg) 26.8 ± 3.3 25.9 ± 2.2 0.285
MCHC (g/dl) 300.1 ± 9.6 297.4 ± 7.5 0.255
Platelet Count 109 /L 360.8 ± 138.3 256.6 ± 60.5 <0.001
Total WBC Count 109/L 10.3 ± 3.3 5.2 ± 1.1 <0.001
Table 1: Haematological Parameters of  Patients with SCA and Controls
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significant lower MCHC (28.4.0 ± 10.7) compared to
HbSS patients with severe autosplenectomy (30.7.0 ±
7.3), moderate autosplenectomy (30.1.6 ± 8.4), mild
autosplenectomy  (30.1.6 ±  6.93) and normal spleen
( 29.7.8 ± 7.55) respectively [F (4,35) = 6.338, p = 0
.001].
Haemoglobin and haematocrit (Hct) were significantly
lower in patients with splenic size smaller than the
normal size (Table 2).  The variation in WCC, platelet
count and number of ISC among the patients were
not significant even though platelet count and WCC
were lowest among patients with splenomegaly.
Spearman’s correlation of  the haematological profile
with splenic sizes showed that Hct values of SCA
patients had a statistically significant positive correlation
with splenic size (r = 0.371, p = 0.019) (Table 3).  There
was a statistically significant negative correlation
between MCV (r = -0.340, p = 0.032), MCH (r = -





Age (years) -0.144 0.377
Haematocrit (%) 0.371* 0.019
Haemoglobin (g/L) 0.265 0.099
MCV(fl) -0.340* 0.032
MCH (pg) -0.418 0.007
MCHC (g/dl) -0.527** <0.001
Platelet count (109/L) -0.353* 0.026
Total WBC count(109/L) -0.039 0.810
ISC per high power field -.107 0.512
Table 3: Correlation between haematological
parameters and splenic length in sickle cell anaemia
patients









Turkey HSD± ± ± ± ±
Hct (%) 25.6±5.5 22.2±5.3 22.4±3.6 29.4±4.8 28.2±3.6 0.006 4>2 & 3
Hb (g/l) 78.8±17.5 67.0±15.1 67.8±11.3 88.2±14.7 79.3±10.4 0.013 4>3
MCV(fl) 93.2±7.7 87.4±5.8 91.2±7.9 89.5±10.8 76.3±9.0 0.038 5<1 & 3
MCH(pg) 28.6±2.7 26.2±1.7 27.5±2.6 26.7±3.5 21.7±3.4 0.008 5<1, 3 & 4
MCHC(g/l) 307.0±7.3 301.6±8.4 301.3±6.8 299.0±7.8 284.0±10.7 0.001 5<1, 2, 3 & 4
Platelet
Count(109/L)
388.6±135 376.6±204 408.8±104 342.6±126 191.5±84.6 0.082
WBC(109/L) 9.10±2.0 11.7±3.8 9.93±2.1 11.4±4.4 8.45±4.1 0.333
ISC( HPF)* 5 (3 - 5.5) 14.0(4.0 – 14.0) 4.0(3.0 – 8.50) 3.0(2.0– 10.0) 5.5(3.0 – 7.00) 0.538
*Kruskal-Wallis H test: Median (IQR)
MCH of SCA patients with splenomegaly were
significantly lower than that of SCA patients with severe
and mild autosplenectomy (Table 2). Sickle cell anaemia
patients with splenomegaly also had statistically
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Fig 3: Frequency of  Blood Transfusion in Relation To Spleen Size in Patients with Sickle Cell Anaemia
Figure 2: Comparison of age at first transfusion between sickle cell anaemia patients with autosplenectomy
and normal spleen size
0.418, p = 0.007) MCHC (r = -0.527, p <0.001).and
the splenic size of  patients.
Blood transfusion history of  patients with SCA
and spleen sizes
With regards to blood transfusion pattern, 7/8 (88%)
of HbSS patients with severe autosplenectomy had
ever been transfused. Likewise, 5/5 (100%) of patients
with moderate autosplenectomy and 10/12 (83%) of
patients with mild autosplenectomy in this study had
ever been transfused. In contrast, 8/11 (73%) and 1/
4 (25%) of  patients with normal spleen and
splenomegaly had ever been transfused (p=0.069). The
median age at first transfusion for patients with severe,
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moderate and mild autosplenectomy were 6 years
(IQR= 4.5 to 8.5 years), 5 years (IQR= 3 to 10 years)
and 12 years (IQR= 8 to 13 years) old respectively.
Patients with normal spleen size had higher median
age at first transfusion 13.5years (IQR= 8.50 to 23.5
years). Further analysis showed that there was a
significant difference in age at first transfusion between
autosplenectomy cases and normal spleen (p=0.041)
(Fig. 2).
Patients with severe autosplenectomy had the highest
frequency of blood transfusion with a median of 5
(IQR = 4.5 to 8.5) times. While patients with moderate
and mild autosplenectomy had relatively lower number
of blood transfusion with median of 1 (IQR = 1.0 to
2.0) and 5 (IQR = 2.00; 5.00) times respectively (Fig.
3).
DISCUSSION
The study aims to determine the relationship between
haematological parameters, blood transfusion history
and variations in spleen size of patients with sickle cell
anaemia. The essential splenic changes in SCA are
splenomegaly and subsequent shrinkage in size of
spleen (autosplenectomy)18, 19.   Severe autosplenectomy
in this study is far less than 55.4% reported among
Northern Nigerian patients with SCA and 33.3% of
patients in Turkey but more than the 6.6–15.5%
reported among Eastern Saudi Arabian patients 18,20,21.
Splenomegaly in SCA is unusual after the first decade
of  life, however, in this current study, 10% of  patients
had splenomegaly which is lower the 35.3%
documented in paediatric patients22. This may be due
to relatively older population in our study. Moderate
autosplenectomy observed in 15% of  our patients was
also less than 31% of patients reported in another study
from Nigeria18. The variability of the spleen sizes is
often linked to co-existence of another heamoglobino-
pathy. However, changes could occur in the
sonographic appearance of the spleen in patients with
SCA in a region with improvement in supportive care
and the use of acute and chronic transfusion therapy
which reduces the occurrence of autosplenctomy 23.
The importance of some haematological values of
patients in steady state in predicting clinical severity and
management of SCD has been documented 19.
Comparing haematological parameters in patients with
SCA and normal HbA controls, the Hb and Hct of
patients are significantly less than that of non SCA while
the white cells and platelet counts are higher. This
findings corroborates previous studies 13, 22.
In comparison, the reports on red cell indices are rather
inconsistent. While Akinbami 24 and Omoti 25 both from
different parts of Nigeria reported a lower MHC,
MCV and MCHC in patient than in the controls, these
indices were comparable for both patients and
controls in our study as well as some other studies
from Nigeria by Iheanacheo22. The explanation for
the lower values in patients compared to controls in
the studies were anaemia of chronic disease, infections
and haemolysis. Adeyemo et al in a related study
attributed the low MCV and MCH, to a high frequency
of haemoglobin variants (such as beta thalassaemia
trait) co-existing with HbS26. The reason for similarities
in both patients and controls might be due to similar
environmental and biological factors that determine
these indices while patient are in steady state and are
regular with intake of  their routine drugs. The
biological factor is likely to be a co-inheritance of alpha
or beta-thalassaemia as suggested by Adeyemo et al.
which has similar frequencies in Nigerians with or
without homozygous sickle-cell disease (SS, AA, AS
and AC genotypes)26, 27.
The changes observed in the haematological values
of patients with SCA have been generally attributed
to autosplenectomy in a blanket assumption,
irrespective of the degree of reduction in splenic size28.
This study shows that haematological profiles of
patients with sickle cell anaemia vary in steady state
with splenic size of  the patient. Low Hb, Hct, WCC
and platelet count are established features of
splenomegaly. In contrast to report by previous worker
of lower haemoglobin and haematocrit in sickle cell
anaemia patients with splenomegaly2,9, the patients with
splenomegaly in this study had higher haemoglobin
and haematocrit than patients with autosplenectomy.
There was a significant positive correlation between
spleen size and haematocrit as well as haemoglobin
suggesting that autosplenectomy may be an indicator
of  disease severity. The presence of  modifiers of  the
disease may reduce incidence of autosplenectmy27.
Other forms of  sickle cell disease associated with
splenomegaly could not be detected using
haemaoglobin electrophoresis at alkaline pH 28,29, the
method of  SCA diagnosis in our patients.  This study
contradicts the report by Awotua-Efebo et al. which
did not study patients with autosplenectomy and did
not observe significant differences in haematocrit value
between patients with splenomegaly and those
without3. The significant positive correlation between
the splenic size and haematocrit of  the patients suggests
that the degree of autosplenectomy is a function of
severity of  the disease. It may also suggest that malaria
may not be the only key player in the development of
splenomegaly in adult patients with sickle cell anaemia
particularly as there was less demand for blood
transfusion in these patients. The higher haematocrit in
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patients with normal splenic size and splenomegaly
suggests that haemolytic process may not necessarily
be accelerated in the presence of a spleen, particularly
in the presence of genetic modifiers 30.
The similarity of red cell indices between controls and
patients and significant variation in the red cell indices
of  patients with changes in splenic size suggest a
pathophysiological link between the spleen size and
haematological profile of  the patients. In the SCA
patients, the red cell indices showed significant negative
correlation to the spleen size which was more marked
with MCHC. The patients with normal spleen and
splenomegaly had consistently lower MCV and MCHC
compared to patients with severe autosplenectomy.
Variability in red cell indices with age particularly the
consistent trend for lower values of MCHC occurring
in older children that stabilizes as patients get older
has been linked to and well documented in alpha
thalassemia 31. Concurrent alpha thalassemia in patients
with splenomegaly might be responsible for the
significant lower MCV, MCH and MCHC. Mean cell
haemoglobin concentration (MCHC) is a determinant
of disease severity32. The low intraerythrocytic
concentration of  haemoglobin S as suggested by low
red cells indices retards polymerization of the HbS
and reduces sickling of the cells resulting in longer red
cell survival. This might account for the higher
haematocrit and low frequency of blood transfusion
in patients with normal size spleen and splenomegaly.
The inability to test for the thalassemia status of these
patients is a limitation to this study.
The number of ISCs did not significantly vary with
splenic size corroborating the report by Serjeant 33,
though the same author documented low ISC in sickle
cell anaemia patients with splenomegaly34. The
combination of splenic hostile environment and higher
MCHC favour the sickling process in patients with
moderate autosplenectomy. This might be responsible
for higher number of ISCs in patients with moderate
autosplenectomy compared to the number in patients
with splenomegaly and autosplenectomy.  As MCHC
increases, blood oxygen (O2) affinity decreases with
increased tendency for red cell to sickle33. This is not
the case in patients with autosplenectomy in whom
the hostile environment of the spleen is absent. The
low intra-erythrocytic haemogblobin S as suggested
by reduced MCH and MCHC in patient with
splenomegaly diminishes intravascular sickling and
favour low level of irreversibly sickled cell count.
Among the suggested haematological determinant of
variable clinical severity of SCA, WBC, platelet count
and ISC showed negative correlation with the spleen
size corroborating the suggestion by Gale et al that
autosplenectomy may suggest a severe clinical course35.
The implication of the variation in haematological
parameters with splenic size is reflected in the blood
transfusion history of  the patients. The blood
transfusion requirements of the patients are strongly
associated with the morphological insult the spleen
received as reflected by the splenic size. Patients with
history of splenic sequestration had significantly smaller
spleens than others35. The blood transfusion history
of the patients with evidence of the consequences of
anatomic splenic injury such as mild, moderate and
severe autosplenectomy suggests a more severe clinical
course than patients whose splenic size did not show
evidence of  significant anatomic splenic injury.  More
than 80% of patients with mild, moderate and severe
autosplenectomy have had blood transfusion. In
contrast, about 63% and 25% of  patients with normal
spleen and splenomegaly had ever been transfused.
(P=.047). The mean frequency of blood transfusion
was significantly higher among patient with smaller than
normal spleen size with the highest frequency being
among patients with severe autosplenectomy. The
higher mean rank age at first transfusion in patients
with normal spleen compared with patients with severe
autosplenectomy and moderate autosplenectomy is in
agreement with the observation by McCarville et al. 36
However, our finding does not agree with another
study from Nigeria which reported that transfusion
needs for SCA patients with and without splenomegaly
is similar and blood transfusion requirement had a non-
significant negative correlation with splenic size3. Our
study does not also support the finding by Helvaci et
al.11 that autosplenectomy was associated with less
transfusion in patient’s life time. The younger age at
first transfusion and higher demand for blood
transfusion in patients with severe autosplenectomy
suggest the degree of  autosplenectomy may be used
to determine severity of  clinical course and to identify
patients that may benefit from disease ameliorating
therapy.
CONCLUSION
This work demonstrates a pathophysiological link
between haematological profile and spleen size in
patients with SCA. There were significant variations in
the red cell indices with splenic sizes of the patients
which was more marked with the MCHC.
Autosplenectomy in patients is associated with lower
haematocrit compared to normal spleen size and
spleneomegaly. In view of  the younger age at first
transfusion and higher demand for blood transfusion
in patients with severe autosplenectomy, the degree
of  autosplenectomy may be used to determine severity
of  clinical course of  patients.
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